233 related articles for article (PubMed ID: 36158700)
1. Clinical-radiomics nomogram for identifying HER2 status in patients with breast cancer: A multicenter study.
Fang C; Zhang J; Li J; Shang H; Li K; Jiao T; Yin D; Li F; Cui Y; Zeng Q
Front Oncol; 2022; 12():922185. PubMed ID: 36158700
[TBL] [Abstract][Full Text] [Related]
2. Integration of ultrasound radiomics features and clinical factors: A nomogram model for identifying the Ki-67 status in patients with breast carcinoma.
Wu J; Fang Q; Yao J; Ge L; Hu L; Wang Z; Jin G
Front Oncol; 2022; 12():979358. PubMed ID: 36276108
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma.
Guo Y; Wu J; Wang Y; Jin Y
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553137
[TBL] [Abstract][Full Text] [Related]
4. Development of an ultrasound-based radiomics nomogram to preoperatively predict Ki-67 expression level in patients with breast cancer.
Liu J; Wang X; Hu M; Zheng Y; Zhu L; Wang W; Hu J; Zhou Z; Dai Y; Dong F
Front Oncol; 2022; 12():963925. PubMed ID: 36046035
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients.
Li C; Yin J
Front Oncol; 2021; 11():671354. PubMed ID: 34041033
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-based radiomics nomogram for differentiation of triple-negative breast cancer from fibroadenoma.
Du Y; Zha HL; Wang H; Liu XP; Pan JZ; Du LW; Cai MJ; Zong M; Li CY
Br J Radiol; 2022 May; 95(1133):20210598. PubMed ID: 35138938
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.
Feng S; Yin J
Quant Imaging Med Surg; 2023 Oct; 13(10):6735-6749. PubMed ID: 37869317
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
[TBL] [Abstract][Full Text] [Related]
9. A Nomogram Based on CT Radiomics and Clinical Risk Factors for Prediction of Prognosis of Hypertensive Intracerebral Hemorrhage.
Fang C; An X; Li K; Zhang J; Shang H; Jiao T; Zeng Q
Comput Intell Neurosci; 2022; 2022():9751988. PubMed ID: 36531926
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Prediction of Lymph Node Metastasis of Pancreatic Ductal Adenocarcinoma Based on a Radiomics Nomogram of Dual-Parametric MRI Imaging.
Shi L; Wang L; Wu C; Wei Y; Zhang Y; Chen J
Front Oncol; 2022; 12():927077. PubMed ID: 35875061
[TBL] [Abstract][Full Text] [Related]
11. The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram.
Wang S; Chen Y; Zhang H; Liang Z; Bu J
Front Oncol; 2021; 11():707686. PubMed ID: 34722254
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
Front Oncol; 2021; 11():825429. PubMed ID: 35155214
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm.
Lin F; Wang Z; Zhang K; Yang P; Ma H; Shi Y; Liu M; Wang Q; Cui J; Mao N; Xie H
Front Oncol; 2020; 10():573630. PubMed ID: 33194677
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer.
Li C; Yin J
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441425
[TBL] [Abstract][Full Text] [Related]
15. Feasibility analysis of magnetic resonance imaging-based radiomics features for preoperative prediction of nuclear grading of ductal carcinoma in situ.
Zhao MR; Ma WJ; Song XC; Li ZJ; Shao ZZ; Lu H; Zhao R; Guo YJ; Ye ZX; Liu PF
Gland Surg; 2023 Sep; 12(9):1209-1223. PubMed ID: 37842532
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Nomogram Based on DCE-MRI Radiomics for Predicting Hypoxia-Inducible Factor 1α Expression in Locally Advanced Rectal Cancer.
Li Z; Huang H; Zhao Z; Ma W; Mao H; Liu F; Yang Y; Wang D; Lu Z
Acad Radiol; 2024 May; ():. PubMed ID: 38816315
[TBL] [Abstract][Full Text] [Related]
17. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
18. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging-based radiomics nomogram for predicting tumor grade in endometrial cancer.
Yue X; He X; He S; Wu J; Fan W; Zhang H; Wang C
Front Oncol; 2023; 13():1081134. PubMed ID: 36895487
[TBL] [Abstract][Full Text] [Related]
20. A Mammography-Based Radiomic Nomogram for Predicting Malignancy in Breast Suspicious Microcalcifications.
Chen Y; Jiang H; Li J; Zhang J; Wu P; Dai Z
Acad Radiol; 2024 Feb; 31(2):492-502. PubMed ID: 37940427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
